Better Therapeutics (BTTX) executive Heinen bought 2,280.61 shares for $4,000 at $1.75
Insider transactions reported
Mark Heinen (executive at Better Therapeutics Inc., BTTX) reported that they bought 2,280.61 shares for $4,000 at $1.75 on Jun 24, 2022. After these transactions the filing shows 2,280.61 shares held indirectly (By daughter).
- Reporting person
- Heinen Mark
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jun 24, 2022 | Open-market purchase (P) | Common Stock1 | +2,280.605 | $1.75 | $4,000 | 2,280.605 indirect |
Holdings before and after
- Common Stock: 0 to 2,280.605 indirect, By daughter
Other positions listed
- Common Stock: 20,000 direct
Footnotes from the filing
- 1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.7539 to $1.7576, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Transaction codes in this filing
- Open-market purchase:
- Code P marks a purchase in the open market or a private deal. The insider paid for these securities.
FAQ
What did Heinen report in this BTTX Form 4?
Mark Heinen (executive at Better Therapeutics Inc., BTTX) reported that they bought 2,280.61 shares for $4,000 at $1.75 on Jun 24, 2022. After these transactions the filing shows 2,280.61 shares held indirectly (By daughter).
How many BTTX shares does Heinen hold after this filing?
The filing shows 2,280.61 shares held indirectly (By daughter) after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code P mean on an SEC Form 4?
Code P marks a purchase in the open market or a private deal. The insider paid for these securities.
Historical context for BTTX
Earlier insider filings at BTTX
- Jun 16, 2022SEC Form 4: Armanino Andrew J. bought $20,846 worth of shares (15,000 units at $1.39)
- Jun 14, 2022SEC Form 4: Parker Geoffrey M. bought $36,182 worth of shares (25,000 units at $1.45), increasing direct ownership by 167% to 40,000 units
- Jun 10, 2022SEC Form 4: Heinen Mark bought $7,800 worth of shares (5,000 units at $1.56), increasing direct ownership by 33% to 20,000 units
- Jun 10, 2022SEC Form 4 filed by Granger Elder
- Jun 10, 2022SEC Form 4 filed by Liu Suying
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2021
Follow BTTX and get a push notification the moment its next story breaks.